287.00 +0.36 (0.13%)
After hours: 7:25PM EDT
Commodity Channel Index
|Bid||283.00 x 800|
|Ask||288.66 x 1300|
|Day's Range||283.82 - 288.73|
|52 Week Range||165.23 - 295.55|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||49.61|
|Earnings Date||Jul 29, 2020 - Aug 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||283.91|
Let's dive into three large-cap pharmaceutical and biotech stocks that appear set to grow during the pandemic-induced downturn and the eventual recovery...
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
While the broader market indexes are still down year to date despite strong rebounds in recent weeks, the major biotech exchange-traded funds (ETFs) are in solid positive territory for the year. Granted, not all biotech stocks are doing well. If you've got $3,000 to invest, here are three great biotech stocks to buy right now that have what it takes for long-term success.
While the coronavirus pandemic has disrupted the global economy, Netflix, Nvidia and ServiceNow are among 22 stocks expecting 25%-150% growth in 2020.
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
Dow Jones futures rose and Nasdaq futures fell as coronavirus stock market rally sector rotation continues. China OK'd a national security law for Hong Kong.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
VRTX vs. ILMN: Which Stock Is the Better Value Option?
As optimism surrounding a coronavirus vaccine and consumer activity begin to pick up, Wall Street is expected to trade higher.
The answer is yes. There's no need to build any suspense. Vertex Pharmaceuticals (NASDAQ: VRTX) is definitely a great stock to buy right now, in my view. I've owned the biotech stock for a couple of years.
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. The market performance numbers and the statistics in the tables in this story are as of May 20.
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, let's examine two of the best biotech stocks in the industry; both are companies making rapid progress in treating patients with significant medical needs. Compugen (NASDAQ: CGEN) specializes in clinical-stage cancer immunotherapies, which have proprietary algorithms used to detect specific sequences within protein receptors that regulate the immune system and inhibit autoimmune activity.
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use.
Vertex Pharmaceuticals (VRTX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.